These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24326407)

  • 41. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program.
    Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A
    J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacists belong in accountable care organizations and integrated care teams.
    Smith M; Bates DW; Bodenheimer TS
    Health Aff (Millwood); 2013 Nov; 32(11):1963-70. PubMed ID: 24191087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving care transitions: current practice and future opportunities for pharmacists.
    ; Hume AL; Kirwin J; Bieber HL; Couchenour RL; Hall DL; Kennedy AK; LaPointe NM; Burkhardt CD; Schilli K; Seaton T; Trujillo J; Wiggins B
    Pharmacotherapy; 2012 Nov; 32(11):e326-37. PubMed ID: 23108810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacists' provision of continuity of care to patients with human immunodeficiency virus infection.
    Foisy MM; Tseng A; Blaikie N
    Am J Health Syst Pharm; 1996 May; 53(9):1013-7. PubMed ID: 8744462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of pharmacist-provided point of care testing.
    Kuhn CH
    J Am Pharm Assoc (2003); 2015; 55(6):572-573. PubMed ID: 26547594
    [No Abstract]   [Full Text] [Related]  

  • 50. Sequential simulation of a patient journey.
    Weldon SM; Ralhan S; Paice L; Kneebone R; Bello F
    Clin Teach; 2017 Apr; 14(2):90-94. PubMed ID: 27329830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Decision Support and Optional Point of Care Testing of Renal Function for Safe Use of Antibiotics in Elderly Patients: A Retrospective Study in Community Pharmacy Practice.
    Heringa M; Floor-Schreudering A; De Smet PAGM; Bouvy ML
    Drugs Aging; 2017 Nov; 34(11):851-858. PubMed ID: 29119468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Health promotion and prevention : what role for community pharmacists ?].
    Gaspar A; Lecomte F; Delwaide AL; Crunenberg R; Louis F; Philippe G
    Rev Med Liege; 2024 Jun; 79(5-6):291-296. PubMed ID: 38869114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A smartphone-based system for the automated management of point-of-care test results in hospitals.
    Jang D; Shin SY; Seo DW; Joo S; Huh SJ
    Telemed J E Health; 2015 Apr; 21(4):301-5. PubMed ID: 25654664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Missed opportunities for HIV screening in pharmacies and retail clinics.
    Dugdale C; Zaller N; Bratberg J; Berk W; Flanigan T
    J Manag Care Spec Pharm; 2014 Apr; 20(4):339-45. PubMed ID: 24684638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies.
    McKeirnan K; Kherghehpoush S; Gladchuk A; Patterson S
    Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33923668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of Point-of-Care Testing (POCT) Services by Community Pharmacists in Osun State Nigeria.
    Maduabuchi Ihekoronye R; Oore-Ofe Akande D; Patrick Osemene K
    Innov Pharm; 2023; 14(3):. PubMed ID: 38487390
    [No Abstract]   [Full Text] [Related]  

  • 57. Cholesterol Point-of-Care Testing for Community Pharmacies: A Review of the Current Literature.
    Haggerty L; Tran D
    J Pharm Pract; 2017 Aug; 30(4):451-458. PubMed ID: 27121870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Pharmacists and Pharmacy Education in Point-of-Care Testing.
    Kehrer JP; James DE
    Am J Pharm Educ; 2016 Oct; 80(8):129. PubMed ID: 27899825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancing availability of services to control hypertension through a team-based care approach that includes pharmacists.
    Wilson CC; Therrien NL; MacLeod KE; Soloe C; Johnson M; Rivera MD; Jordan J; Shantharam S; Minaya-Junca J; Fulmer EB; Choe HM
    J Am Pharm Assoc (2003); 2024; 64(3):102055. PubMed ID: 38401838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Access and Quality of HIV-Related Point-of-Care Diagnostic Testing in Global Health Programs.
    Fonjungo PN; Boeras DI; Zeh C; Alexander H; Parekh BS; Nkengasong JN
    Clin Infect Dis; 2016 Feb; 62(3):369-374. PubMed ID: 26423384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.